Cardiac amyloidosis detection by early bisphosphonate (99mTc-HMDP) scintigraphy

Abstract

Objective

To determine one or more indexes able to detect the presence of cardiac amyloidosis (CA) from planar scintigraphy images after injection of 99mTc-HMDP tracer and to identify the earliest acquisition time able to ensure an accurate diagnosis of amyloid transthyretin CA.

Methods and Results

A total of 38 patients were included: 18 subjects with a final diagnosis of ATTR-CA and 20 controls. Dynamic planar images of the anterior thorax were acquired, starting at intravenous injection of ≈ 700 MBq of 99mTc-HMDP. From time/activity curves (TAC) of regions of interest such as heart, vascular region, right ribcage, and soft tissues, several indices were considered. From the analysis, it resulted that both TACHeart/Bone(t) and RIheart–bone(t), for t > 6 minutes, well distinguish ATTR-CA patients from controls subjects. This is confirmed by the area under curves (AUC) analysis giving AUC values =.9 at t ≅ 6 minutes and AUC ≅ 1 for t > 10 minutes.

Conclusions

The method proposed allows determining the presence of ATTR-CA, in an inexpensive manner both in terms of examination costs and time spent.

This is a preview of subscription content, log in to check access.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Abbreviations

AL:

Immunoglobulin light-chain derived amyloidosis

ATTR:

Transthyretin derived amyloidosis

AUC:

Area under curves

CA:

Cardiac amyloidosis

HMDP:

Hydroxymethylene diphosphonate

nRMSE:

Normalized root mean square error

RI:

Retention index

ROI:

Region of interest

SEM:

Standard error measure

TAC:

Time/activity curve

References

  1. 1.

    Singh V, Falk R, Di Carli MF, Kijewski M, Rapezzi C, Dorbala S. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis. J Nuclear Cardiol 2019;26:158-73.

    Article  Google Scholar 

  2. 2.

    Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016;133:2404-12.

    CAS  Article  Google Scholar 

  3. 3.

    Ansari-Lari MA, Ali SZ. Fine-needle aspiration of abdominal fat pad for amyloid detection: A clinically useful test? Diagn Cytopathol 2004;30:178-81.

    Article  Google Scholar 

  4. 4.

    Fine NM, Arruda-Olson AM, Dispenzieri A, Zeldenrust SR, Gertz MA, Kyle RA, Swiecicki PL, Scott CG, Grogan M. Yield of noncardiac biopsy for the diagnosis of transthyretin cardiac amyloidosis. Am J Cardiol 2014;113:1723-7.

    CAS  Article  Google Scholar 

  5. 5.

    Falk RH, Quarta CC. Echocardiography in cardiac amyloidosis. Heart Fail Rev 2015;20:125-31.

    Article  Google Scholar 

  6. 6.

    Cappelli F, Baldasseroni S, Bergesio F, Perlini S, Salinaro F, Padeletti L, et al. Echocardiographic and biohumoral characteristics in patients with AL and ATTR amyloidosis at diagnosis. Clin Cardiol 2015;38:69-75.

    Article  Google Scholar 

  7. 7.

    Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, et al. Magnetic resonance in transthyretin cardiac amyloidosis. J Am Coll Cardiol 2017;70:466-77.

    CAS  Article  Google Scholar 

  8. 8.

    Fontana M, Chung R, Hawkins PN, Moon JC. Cardiovascular magnetic resonance for amyloidosis. Heart Fail Rev 2015;20:133-44.

    CAS  Article  Google Scholar 

  9. 9.

    Tang CX, Petersen SE, Sanghvi MM, Lu GM, Zhang LJ. Cardiovascular magnetic resonance imaging for amyloidosis: The state-of-the-art. Trends Cardiovasc Med 2019;2:83-94.

    CAS  Article  Google Scholar 

  10. 10.

    Pelletier-Galarneau M, Abikhzer G, Giraldeau G, Harel F. Molecular imaging of cardiac amyloidosis. Curr Cardiol Rep. 2019. https://doi.org/10.1007/s12350-020-02177.

    Article  PubMed  Google Scholar 

  11. 11.

    Genovesi D, Vergaro G, Emdin M, Giorgett A, Marzullo P. PET-CT evaluation of amyloid systemic involvement with [18F]-florbetaben in patient with proved cardiac amyloidosis: A case report. J Nucl Cardiol 2017;24:2025-9.

    Article  Google Scholar 

  12. 12.

    Giorgetti A, Genovesi D, Emdin M. Cardiac amyloidosis: The starched heart. J. Nucl. Cardiol 2020;27:133-6.

    Article  Google Scholar 

  13. 13.

    Cappelli F, Gallini C, DiMario C, Costanzo EN, Vaggelli L, Tutino F, et al. Accuracy of 99mTc-hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol 2019;26:497-504.

    Article  Google Scholar 

  14. 14.

    Andrikopoulou E, Bhambhvani P. Nuclear imaging of cardiac amyloidosis. J Nucl Cardiol 2019;26:505-8.

    Article  Google Scholar 

  15. 15.

    Bravo PE, Dorbala S. Targeted Nuclear Imaging Probes for Cardiac Amyloidosis. Curr Cardiol Rep. 2017;19:59.

    Article  Google Scholar 

  16. 16.

    Treglia G, Glaudemans AWJM, Bertagna F, Hazenberg BPC, Erba PA, Giubbini R, et al. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: A bivariate meta-analysis. Eur J Nuclear Med Mol Imaging 2018;45:1945-55.

    CAS  Article  Google Scholar 

  17. 17.

    Ramsay SC, Lindsay K, Fong W, Patford S, Younger J, Atherton J. Tc-HDP quantitative SPECT/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population. Eur J Hybrid Imaging. 2018;2:17.

    Article  Google Scholar 

  18. 18.

    Galat A, Van der Gucht A, Guellich A, Bodez D, Cottereau A, Guendouz S, et al. Early phase 99Tc-HMDP scintigraphy for the diagnosis and typing of cardiac amyloidosis. JACC 2017;10:601-3.

    PubMed  Google Scholar 

  19. 19.

    Chen W, Ton VK, Dilsizian V. Clinical phenotyping of transthyretin cardiac amyloidosis with bone-seeking radiotracers in heart failure with preserved ejection fraction. Curr Cardiol Rep. 2018;20:23.

    Article  Google Scholar 

  20. 20.

    Perugini E, Guidalotti PL, Salvi F, Cooke RMT, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scin- tigraphy. J Am Coll Cardiol 2005;46:1076-84.

    Article  Google Scholar 

  21. 21.

    Kristen AV, Scherer K, Buss S, Aus Dem Siepen F, Haufe S, Bauer R, et al. Noninvasive risk stratification of patients with transthyretin amyloidosis. JACC 2014;7:502-10.

    PubMed  Google Scholar 

  22. 22.

    Bokhari S, Castano A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light- chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 2013;6:195-201.

    Article  Google Scholar 

  23. 23.

    Gallini C, Tutino F, Martone R, Ciaccio A, Costanzo EN, Taborchi G, et al. Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy. J Nucl Cardiol. 2019 [Epub ahead of print].

  24. 24.

    Gillmore JD, Wechalekar A, Bird J, et al. Guidelines on the diagnosis and investigation of AL amyloidosis. Br J Haematol 2015;168:207-18.

    CAS  Article  Google Scholar 

  25. 25.

    Antoni G, Lubberink M, Estrada S, Axelsson J, Carlson K, Lindsjö L, et al. In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med 2013;54:213-20.

    CAS  Article  Google Scholar 

  26. 26.

    Law WP, Moore PT, Ng ACT, Wang WYS, Mollee PN. Cardiac amyloid imaging with 18F-florbetaben PET: A pilot study. J Nucl Med 2016;57:1733-9.

    CAS  Article  Google Scholar 

  27. 27.

    Popović ZB, Thomas JD. Assessing observer variability: A user’s guide. Cardiovasc Diagn Ther 2017;7:317-24.

    Article  Google Scholar 

  28. 28.

    Pelletier-Galarneau M, Abikhzer G, Giraldeau G, Harel F. Molecular imaging of cardiac amyloidosis. Curr Cardiol Rep. 2019;21:12.

    Article  Google Scholar 

  29. 29.

    Treglia G, Glaudemans AWJM, Bertagna F, Hazenberg BPC, Erba PA, Giubbini R, Ceriani L, Prior JO, Giovanella L, Slart RHJA. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: A bivariate meta-analysis. Eur J Nucl Med Mol Imaging 2018;45:1945-55.

    CAS  Article  Google Scholar 

  30. 30.

    Papantoniou V, Valsamaki P, Kastritis S, Tsiouris S, Delichas Z, Papantoniou Y, et al. Imaging of cardiac amyloidosis by (99m)Tc- PYP scintigraphy. Hell J Nucl Med 2015;18:42-50.

    PubMed  Google Scholar 

  31. 31.

    Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: Predicting survival for patients with AATTR cardiac amyloidosis. JAMA Cardiol 2016;1:880-9.

    Article  Google Scholar 

  32. 32.

    Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2- propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging 2011;38:470-8.

    Article  Google Scholar 

  33. 33.

    Galat A, Rosso J, Guellich A, Van Der Gucht A, Rappeneau S, Bodez D, et al. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis. Amyloid 2015;22:210-20.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to M. F. Santarelli PhD.

Ethics declarations

Disclosure

No potential conflict of interest relevant to this article was reported.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarizes the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.

All editorial decisions for this article, including selection of reviewers and the final decision, were made by guest editor Stephan Nekolla, MD.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PPTX 299 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Santarelli, M.F., Genovesi, D., Positano, V. et al. Cardiac amyloidosis detection by early bisphosphonate (99mTc-HMDP) scintigraphy. J. Nucl. Cardiol. (2020). https://doi.org/10.1007/s12350-020-02239-5

Download citation

Keywords

  • Cardiac amyloidosis
  • Amyloid transthyretin (ATTR)
  • Early 99mTc-HMDP scintigraphy
  • Dynamic time-activity curves
  • Retention index